The similarity of the kinase domains between mTOR and PI3Ks and the importance of PI3K signaling dependent of mTOR can cause ATP-competitive PI3K/mTOR kinase inhibitors to serve a key function in targeted cancer treatment. Here, MTOR is linked to cancer.